Clinical Trial Update: [68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating [68Ga]DOTATATE-PET/MRI in hepatocellular carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• [68Ga]DOTATATE-PET/MRI

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-01-10